In this study, we investigated the relaxant action of galetin 3,6-dimethyl ether (FGAL) on rat aorta. The flavonoid relaxed both PMA-and phenylephrine (Phe)-induced contractions (pD2 = 5.36 ± 0.11 and 4.17 ± 0.10, respectively), suggesting the involvement of PKC and Phe pathways or α1 adrenergic receptor blockade. FGAL inhibited and rightward shifted Phe-induced cumulative concentration-response curves, indicating a noncompetitive antagonism of α1 adrenergic receptors. The flavonoid was more potent in relaxing 30 mM KCl-than 80 mM KCl-induced contractions (pD2 = 5.50 ± 0.22 and 4.37 ± 0.12). 
The vasorelaxant potency of FGAL on Phe-induced contraction was reduced in the presence of 10 release from the sarcoplasmic reticulum (SR). FGAL potentiated the relaxant effect of aminophylline and sildenafil but not milrinone, suggesting the involvement of phosphodiesterase V (PDE V). Thus, the FGAL vasorelaxant mechanism involves noncompetitive antagonism of α1 adrenergic receptors, the non-selective opening of K + channels, inhibition of Ca 2+ influx through CaV or ROCs and the inhibition of intracellular Ca
Introduction
Flavonoids are a large class of polyphenolic substances found in plants [1] known for their interesting activities in vascular diseases [2] [3] [4] . Several pharmacological effects have been described for this class of secondary metabolites, such as inhibition of enzymes involved in the synthesis of reactive oxygen species, such as xanthine oxidase, NADPH oxidase and lipoxygenase [5] , increase in nitric oxide (NO) production in vascular smooth muscle [6] and spasmolytic activity in various models of smooth muscle [7, 8] . Furthermore, some flavonoids are known for their actions on vascular tone, such as quercetin, kaempferol, luteolin, apigenin, catechin and epicatechin [1] .
Galetin 3,6-dimethyl ether (FGAL) (Figure 1 ), a flavonoid isolated from the plant Piptadenia stipulacea (Benth.) Ducke, has exhibited some pharmacological activities, such as antiviral [9] , antinociceptive and anti-inflammatory activities in mice [2] , as well as non-selective spasmolytic activity in smooth muscles (e.g., guinea-pig ileum and trachea and rat uterus and aorta). Moreover, this flavonoid has shown the highest relaxant potency in rat aorta, and this effect is independent of endothelium-derived relaxant factors (EDRF) [10] .
Regarding the pharmacological effects described for flavonoids, these secondary metabolites appear to be candidates for the treatment of various diseases caused by disorders of smooth muscle, especially those affecting the cardiovascular system, such as hypertension, atherosclerosis and ischemic infarction [1] . Therefore, the aim of this work was to characterize the mechanisms involved in vasorelaxation induced by the flavonoid FGAL in rat aorta. 
Results and Discussion
In blood vessels, the endothelium plays an important role in regulating vascular smooth muscle tone by releasing endothelium-derived relaxing factors (EDRF) [11] , including endothelium-derived hyperpolarizing factor (EDHF), nitric oxide (NO), prostacyclins and epoxyeicosatrienoic acids [12] . Despite this, it was previously demonstrated that the vasorelaxation induced by FGAL is independent of EDRF, since it relaxed aorta in both the absence and presence of endothelium in an equipotent manner [10] . On the other hand, several mechanisms are involved in endothelium-independent vasorelaxation, such as Ca release from the sarcoplasmic reticulum (SR) and phosphodiesterase (PDE) pathway inhibition [13] . Moreover, it has been demonstrated that flavonoids can produce vasorelaxation by different mechanisms, such as NO release from endothelium [14] , PKC and PDE inhibition [15, 16] , blockade of Ca 2+ influx through voltage-sensitive Ca 2+ channels (CaV) [17] and K + channel activation (IKCa and BKCa) [18, 19] .
PKC is a key protein to vascular smooth muscle contraction [20] . This protein kinase can both activate CaV and inhibit K + channels, leading to Ca 2+ influx and contributing to the contractile process. Phorbol esters, such as phorbol 12-myristate 13-acetate (PMA), which are described as PKC stimulators, are used as exogenous activators of this protein kinase. Also, they have been known to induce sustained contraction in several arterial tissues [21, 22] . FGAL (10 M PMA (pD2 = 4.17 ± 0.10). According to the pD2 values, FGAL was about 16-fold more potent in relaxing aorta pre-contracted with Phe than with PMA. The vehicle did not show a significant relaxant effect in rat aorta pre-contracted with either contractile agent (Figure 2) .
The fact that PMA and Phe elicit contraction by different pathways suggests that the relaxant effect of FGAL in rat aorta involves both mechanisms. Therefore, the flavonoid can act on PKC (PMA exclusive target) as well as CaV, K + channels and Ca 2+ mobilization from SR, which are involved in Phe signaling but are not directly affected by PMA [23] . Figure 2 shows that the inhibition of PKC is possibly involved, but that other targets (e.g., CaV, K + channels or others) are involved in a major manner. Moreover, we do not discard a possible direct antagonism of α1 adrenergic receptors by FGAL.
To assess the blockade of α1 adrenergic receptors by FGAL, the effect of the flavonoid on cumulative concentration-response curves to phenylephrine (10 M) rightward shifted these curves in a non-parallel manner with reduction in Emax and pD2 values of phenylephrine (Table 1, Figure 3 ). The FGAL pD2 value in inhibiting the effect of phenylephrine was 4.94 ± 0.04. In presence of a noncompetitive antagonist, the agonist has its maximum effect suppressed and abolished at higher concentrations of the antagonist [24] . Thus, according to the data obtained, FGAL showed the profile of a noncompetitive antagonist acting on α1 adrenergic receptors, which can be associated with a blockade of downstream pathways, such as CaV, K + channels and SR Ca M PMA (FGAL: Δ, n = 5; vehicle: ◊, n = 3) in rat aorta. Symbols and vertical bars represent the mean ± S.E.M., respectively. Student's t-test, ***p < 0.001 (Phe vs. PMA). To confirm the activation of K + channels by FGAL, the non-selective blocker of these channels TEA + (10 mM) was employed as a pharmacological tool. The relaxant potency of FGAL was reduced in the presence of the blocker (about 4-fold), confirming the participation of K + channels in relaxation induced by FGAL ( Figure 5 , Table 2 ). The vascular smooth muscle expresses multiple K + channel subtypes, where KATP, Kir, KV, BKCa and SKCa are the most expressed subtypes [27] . Hence, the involvement of these subtypes of K + channels was evaluated by employing their selective blockers. The relaxation induced by FGAL was not changed in the presence of 1 mM TEA + , excluding the participation of BKCa. Conversely, the relaxant potency of the flavonoid was reduced in the presence of glibenclamide, BaCl2, 4-AP and apamin, indicating the activation of KATP, Kir, KV and SKCa, respectively, by FGAL to induce vasorelaxation in rat aorta (Table 2 ). Table 2 . Emax (%) and pD2 values of FGAL in both the absence and presence of K + channel blockers in rat aorta. Data are expressed as the mean ± S.E.M. (n = 5). One-way ANOVA followed by Dunnett's post-test. * p < 0.05, ** p < 0.01 (FGAL vs. FGAL + blockers). Similar results are described in the literature for other flavonoids that promote relaxation in rat aorta through the activation of K + channels; for example, pinocembrin activates KATP, KCa and KV [28] , (-)-epigallocatechin-3-gallate activates KATP, SKCa, IKCa and BKCa [29] , and quercetin acts on BKCa [30] .
Cytosolic calcium concentration ([Ca   2+ ]i) increase in vascular smooth muscle cell is essential for its contraction and can occur by ion influx from the extracellular medium [31] or by release from intracellular stores [32] . The Ca 2+ influx in vascular smooth muscle cells involves the opening of CaV and ROCs [33] . Pharmacological assays showed that the tonic contraction induced by high [K + ]o is mainly due to the depolarization of smooth muscle cells and consequent Ca 2+ influx through CaV, while the contraction induced by Phe is caused by Ca 2+ influx through both CaV and ROCs [34] [35] [36] . Given this and since FGAL caused more potent relaxation (about 6-fold) in aorta pre-contracted with Phe (pD2 = 5.36 ± 0.11) than that with 80 mM KCl (pD2 = 4.37 ± 0.12), it is suggested that FGAL may reduce the Ca 2+ influx through both CaV and ROCs. To assess this hypothesis, we evaluated the effect of FGAL on CaCl2-induced contractions in depolarizing medium nominally without Ca M) inhibited these cumulative concentration-response curvesand this effect was concentration dependent. These curves were rightward shifted in a non-parallel manner with reduction in Emax and pD2 values of CaCl2 (Table 3, Figure 6 ). The pD2 value of FGAL in inhibiting the effect of CaCl2 was 4.44 ± 0.05. Figure 7 ). The FGAL pD2 value in inhibiting the effect of CaCl2 was 5.07 ± 0.06. Together, these results confirm that FGAL inhibits Ca 2+ influx by blocking both CaV and ROCs to relax vascular smooth muscle. However, comparing the inhibitory effect of FGAL in Figures 6 and 7 , the potency of the flavonoid was higher in the presence of verapamil and Phe than in their absence. This therefore indicates that FGAL acts mainly by inhibiting ROCs. 
Contraction (%)
PDEs are widely distributed in mammalian tissues and hydrolyze cAMP and cGMP, resulting in their inactive products 5'-AMP and 5'-GMP, which do not activate PKA and PKG, respectively, thus stopping the cell signaling mechanism dependent on increased cyclic nucleotides [38] . Substances able to raise intracellular levels of cAMP or cGMP show a strong relaxant effect, which can be due to PDE inhibition [39] . Some flavonoids from different plant species inhibit PDEs [40] , for instance (-)-epigallocatechina-3-gallate in rat aorta [29] . Therefore, to assess the possible involvement of cyclic nucleotide-PDE pathway, we determined the relaxant effect of aminophylline, a non-selective PDE inhibitor, in both the absence and presence of FGAL. The relaxant effect induced by aminophylline (10 M, positive control) (pD2 = 4.36 ± 0.09) was potentiated about 4-fold in the presence of FGAL (pD2 = 5.13 ± 0.24), confirming that FGAL inhibits cyclic nucleotide-PDE pathways to relax rat aorta. Additionally, in vascular smooth muscle, PDE III and V are the most expressed PDE subtypes [38] , and interestingly, the relaxation curve induced by sildenafil (10 M) (pD2 = 7.23 ± 0.23), a PDE III inhibitor, was not changed in the presence of the flavonoid (pD2 = 7.28 ± 0.09) (Figure 9) .
Thus, these results indicate that PDE V but not PDE III pathway is involved in relaxation induced by FGAL in rat aorta. 
Experimental

Chemicals
The flavonoid FGAL was obtained according to the reported method [2] . Aminophylline, apamin, barium chloride (BaCl2), Cremophor EL ® , glibenclamide, phenylephrine (Phe), phorbol 12-myristate-13-acetate (PMA), tetraethylammonium chloride (TEA + ), verapamil and 4-aminopyridine (4-AP) were obtained from Sigma-Aldrich (Duque de Caxias, RJ, Brazil). Milrinone was obtained from Sanofi-Aventis (São Paulo, SP, Brazil) and sildenafil was obtained from Nutrifarm (São Paulo, SP, Brazil). All substances were dissolved in distilled water, except glibenclamide, which was dissolved in ethanol and diluted in distilled water, and FGAL, which was dissolved in 3% Cremophor EL ® and diluted in distilled water to 10 
Animals
Male Wistar rats (Rattus norvegicus) weighing 250-350 g from Bioterium Professor Thomas George of Centro de Biotecnologia (CBiotec/UFPB) were used. The animals were maintained in a 12 h light/dark cycle (lights on: 06:00-18:00 h), under controlled temperature (21 ± 1 °C), with free access to food and water. Animal welfare and experimental procedures were followed in accordance with the Ethical Principles for Care and Use of Laboratory Animals of the Brazilian Society for Laboratory Animal Science, approved by the Animal Research Ethics Committee (CEPA) of "Laboratório de Tecnologia Farmacêutica" (LTF/UFPB, protocol 0105/10).
Preparation of Rat Aortic Rings
The animals were euthanized by cervical dislocation followed by sectioning of cervical vessels. Rat aorta was immediately removed, immersed in Krebs solutions and bubbled with carbogen mixture (95% O2 and 5% CO2). The Krebs solution composition was (mM): NaCl (118.0), KCl (4.55), MgSO4 (5.7), KH2PO4 (1.1), CaCl2 (2.52), NaHCO3 (25.0) and glucose (11.0), with pH adjusted to 7.4. The Krebs depolarizing solution nominally without Ca 2+ was made with 80 mM KCl in equimolar exchange for NaCl, and the Ca 2+ -free Krebs solution with the addition of 3 mM EDTA, both with omission of CaCl2. Aortic rings (2-3 mm) were immersed in organ baths with 5 mL of Krebs solution, at 37 °C and bubbled with carbogen mixture.
To record isometric contractions, aortic segments were suspended with steel rods and connected to force transducers (FORT-10) attached to an amplifier (TMB4M), both from World Precision Instruments (Sarasota, FL, USA) and connected to an A/D converter into a PC running Biomed ® software (BioData, Ribeirão Preto, SP, Brazil). The resting time of aorta was 60 min in a preload tension of 1 g (baseline). During the organ resting phase, the solution was changed every 15 min to avoid metabolite accumulation. In the experiments, the integrity of endothelium was not verified, since the relaxant effect exhibited by FGAL was similar either in its absence and presence [10] . M phorbol 12-myristate 13-acetate (PMA), a protein kinase C (PKC) activator [41] . During the sustained phase of the contraction, FGAL (10 M) was obtained [47] . The Emax obtained with the control was taken as 100%, and all concentration-response curves in the presence of FGAL were assessed referring to it. The pD2 value of CaCl2 was calculed based on the Emax reached in the presence of different concentrations of FGAL. , and 3 × 10 −5 M) was incubated at different concentrations and in different preparations, and a third cumulative concentration-response curve with CaCl2 was obtained [48] . The Emax obtained with the control was taken as 100%, and all concentration-response curves to CaCl2 in the presence of FGAL were assessed referring to it. The pD2 value of CaCl2 was determined on the basis of the Emax obtained in the presence of different concentrations of FGAL. M Phe [28] . The inhibition of the phasic contractions induced with Phe was calculated by comparing the contractile response in both the absence and presence of FGAL. M), a PDE V inhibitor [38] , were added to the organ bath, in different experiments, to obtain a relaxation curve. Their relaxation potency was evaluated by comparing their pD2 values in both the absence and presence of FGAL.
Experimental Protocols
Statistical Analysis
Data were expressed as the mean and standard error of the mean (S.E.M.). The negative logarithm of FGAL, Phe or Ca 2+ concentration that produced a half-maximal response (pD2, also denoted as pEC50) and the concentration of FGAL that inhibits 50% of maximal response to Phe or CaCl2 (IC50) were determined by non-linear regression [49, 50] . Mean differences were statistically compared using Student's t-test, for two independent groups, or one-way ANOVA followed by Bonferroni's or Dunnett's post-test, for multiple comparisons. The null hypothesis was discarded when p < 0.05. All values were obtained using GraphPad Prism ® 5.01 software (GraphPad Software Inc., La Jolla, CA, USA).
Conclusions
In this work, the mechanism underlying the vasorelaxant action of galetin 3,6-dimethyl ether in rat aorta was elucidated for the first time. This mechanism involves the noncompetitive antagonism of α1 adrenergic receptors and includes the non-selective opening of K + channels, the inhibition of Ca 2+ influx through CaV or ROCs and the inhibition of intracellular Ca 2+ release, which may be by direct or indirect mechanisms. Additionally, there is the involvement of cyclic nucleotide pathways, particularly through PDE V inhibition (Figure 10 ). Taken together, these data suggest that FGAL is a promising flavonoid to be used in the treatment of conditions associated with vascular smooth muscle disorders, such as hypertension or ischemia. 
